Bariatric surgery is considered to be the most effective treatment for morbid obesity. At present, revisional surgery is considered in patients who experience complications, or in whom the intended weight loss is not achieved. However, as there is no consensus on what constitutes failure of primary surgery, there are no guidelines on who should receive revisional surgery. Physical parameters alone may be insufficient and quality of life has emerged as an alternative to provide a holistic appraisal of the outcome of primary surgery and the need for further revisional surgery in bariatric patients. Quality of life surveys such as short form health survey (SF-36) or Moorehead-Ardelt II (MA-II) assess the patients' perception of their weight and can also be used to assess the impact of post-operative complications such as gastro-esophageal reflux disease or dysphagia. However, unrealistic expectations of weight loss have been shown to be prevalent in bariatric patients and patients who seek revisional surgery on the basis of disappointment with the primary outcome are unlikely to be satisfied with the revisional outcome. Indications for re-operative surgery must be tailored to improve the quality and longevity of each individual patient' s life. Long term studies are required to investigate and validate quality of life as an indication for revisional surgery.
INTRODUCTION
Morbid obesity is a major public healthcare burden. Bariatric surgery is now widely accepted as the most effective method in the treatment of morbid obesity and its related co-morbidities, such as type 2 diabetes mellitus.
teria. 6 They noted that amongst the studies reviewed, the most frequently used definition for failure of the primary procedure was < 50% of excess weight lost (EWL), with or without a body mass index (BMI) of greater than 35 kg/m 2 at 18 months post-operation.
Whilst weight loss is a straightforward and easily applied method to select patients for revisional surgery, there are some pitfalls in this approach. %EWL was originally proposed by Reinhold 7 in 1982 as an outcome measure of a patient's response to bariatric surgery.
During that time, the indication for surgical treatment was being 100% above one's ideal weight, and an increase in mortality was associated with patients who had more than 50% excess weight. 8 It is now well recognized that increased morbidity and mortality are associated with even lower excess weights. This cut-off of 50% EWL is thus a reinterpretation of the principle proposed by Reinhold and is in actuality a rather arbitrary target of success. %EWL as it is used today, describes weight loss relative to an ideal BMI of 25, which is also problematic because this is not a feasible target for patients who are > 50 kg/m 2 . 9 Furthermore, recently published studies have found other outcomes measures such as expected BMI loss (when corrected for pre-operative BMI) 9 or percentage weight change, as is used in major prospective studies, to be more accurate methods of weight loss reporting. 10, 11 However, looking more broadly, there is also an observable variation in the expected weight loss depending on the operation performed. A recent meta-analysis found that there was a difference in mean reduction in BMI between different procedures: 12-17 kg/ m 2 for sleeve gastrectomy compared to only 2 kg/m 2 in adjustable gastric banding showing that if weight loss outcomes were to be used as an indication for revision, then it would need to be adjusted for the primary bariatric procedure itself as well. 12 Various studies have also reported that 20-30% of patients fail to achieve successful weight loss 13, 14 , the implication being that these patients should then require revisional surgery. Unfortunately, using weight loss alone as an indication does not take into account patients who may be 'metabolically healthy obese' i.e. patients that may fail to achieve target weight loss but do not suffer from metabolic complications associated with morbid obesity. 15 Revisional surgery is associated with a higher risk of complications than primary bariatric surgery, and in these patients this risk is unlikely to outweigh the benefits of further weight loss that may be achieved with re-operation. It also fails to account for patients who achieve the targeted weight loss but may still be at risk of obesity related co-morbidities as it has been shown that reduction in %EWL does not necessarily correlate with an unequivocal reduction in health risk. 16 It is interesting to note that there were no studies that considered non-resolution of co-morbidities as an indication for revisional surgery. 6 These concerns highlight a need for more selective criteria in determining candidates for revisional surgery such that patients who would benefit from re-operation are able to receive it.
Quality of life as an indicator
To redefine the selection process for revisional surgery, it may be worth reflecting on the definition of revisional surgery itself. As laid out by the American Society of Metabolic and Bariatric Diseases task force, revisional surgery can be broadly categorised into conversions, corrective procedures or reversals to tackle inadequate response to surgery, complications or intolerance to complications brought on by surgery. 5 From a clinician's perspective, inadequate response to surgery is measured by weight loss reported or remission of co-morbidities, however it may be valuable to also consider the patient's perspective. It is known that often patients seek bariatric surgery on the basis of severity of psychological distress associated with their morbid obesity, rather than absolute weight gain above the norm. 17 Hence, their opinion of the success or failure of Moorehead-Ardelt II (MA-II), which both take into account factors such as appearance, physical health, social functioning, mental health and so on. These surveys have both been used in studies looking at quality of life after bariatric procedures. 18 Patients that feel that the improvement in their quality of life is not as much as A study conducted by Mohos et al. 18 compared the quality of life of patients after primary and revisional laparoscopic Roux-en-Y gastric bypass (LRYGB) using both SF-36 and MA-II as measurements of quality of life. Although there was no statistically significant difference found between quality of life in both groups using either survey, the scores achieved by both groups corresponded to acceptable standards of quality of life as compared to the normal European population. More studies like these are needed to investigate the impact of revisional surgery on quality of life in patients.
Complications or intolerance effects from the primary procedures are also strong indications for revisional surgery. In the same study by Mohos et al. 18 , they reported 657 patients who underwent LRYGB and 81 patients who underwent revisional LRYGB of which 62 were for inadequate weight loss, 11 were for gastroesophageal reflux disease (GERD) and 8 were for dysphagia. Of the patients that underwent revision for GERD and dysphagia, all of them had presented post-operatively complaining of symptoms that were affecting their quality of life. In another study, severe nutritional deficiency was noted in 1% of patients post LRYGB who presented with severe diarrhoea and swelling resistant to pancreatic enzyme replacement and anti-diarrheal agents. 19 Similarly, another study considered patients that presented almost 5 years post LRYGB with gastroscopy proven bile reflux which manifested as pain, vomiting and dysphagia, revisional surgery was performed in which the alimentary limb was lengthened and the symptoms resolved. 20 The symptoms that these patients present with are a reflection of the underlying technical complications of the primary procedure that are amenable to correction. Such factors can be examined post-operatively and monitored in addition to weight loss and psychosocial wellbeing, to provide a holistic appraisal of the outcome of primary surgery and assess whether there is a need for a revisional procedure.
However, it is important to recognise that there may be certain pitfalls to using quality of life alone as an indicator for revisional surgery. Obese patients that seek surgical treatment have been shown to have more severe general psychopathology compared to obese patients that choose medical or conservative therapies. 17 Furthermore, unrealistic expectations of weight loss have been shown to be prevalent in obesity surgery patients. A study of 284 prospective candidates for bariatric surgery, patients stated that their "dream" weight loss was 89+/-8% EWL, and would be "disappointed" if their weight loss was 49+/-14%. 21 This is concerning when 50% EWL is considered by most centres to be successful weight loss. Another study evaluating willingness to accept risk in patients seeking bariatric surgery found that majority of patients interviewed were willing to accept some level of mortality risk to undergo surgery, with 19.5% of patients willing to accept a risk of at least 10%. 22 Given that the weight loss outcomes of revisional surgery are understandably significantly less than that of primary bariatric surgery
CONCLUSION
Arbitrary indications based alone on BMI or weight should not be used. Indications for re-operative surgery must be tailored to improve the quality and longevity of each individual patient's life.
Quality of life after primary bariatric surgery is influenced by the effectiveness of weight loss, any complications sustained and by the patient's perception of the experience. It is valuable to consider it as part of a holistic appraisal of success or failure of the primary procedure, to subsequently decide whether revisional surgery is indicated in the patient. Long term studies are required to investigate and validate quality of life as an indication for revision surgery.
